← All companies
EW
Edwards Lifesciences Corporation
$88.82
+2.75 +3.20%
Key statistics
from XBRL data in SEC filingsMarket cap
$51.1B
Revenue (TTM)
$6.30B
Net income (TTM)
$1.10B
EPS (TTM)
$1.88
P/E ratio
47.2
Dividend yield
—
Free cash flow
$1.33B
Cash
$2.45B
Total assets
$13.3B
Gross margin
77.9%
52-week range
$72.30 – $96.29
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Results of operations (earnings release)
Jul 23, 2026
8-K
Director or officer change; Shareholder vote results
May 8, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Director or officer change; Regulation FD disclosure
May 4, 2026
8-K
Results of operations (earnings release)
Apr 23, 2026
10-K
Fiscal year ended 2025-12-31
Feb 25, 2026
8-K
Results of operations (earnings release)
Feb 10, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Director or officer change; Regulation FD disclosure
Oct 30, 2025
8-K
Results of operations (earnings release)
Oct 30, 2025
8-K
Other events
Aug 19, 2025
10-Q
Quarter ended 2025-06-30
Aug 6, 2025
8-K
Regulation FD disclosure
Aug 6, 2025
8-K
Director or officer change
Jul 25, 2025
8-K
Results of operations (earnings release)
Jul 24, 2025
8-K
Director or officer change; Shareholder vote results
May 8, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
Apr 23, 2025
10-K
Fiscal year ended 2024-12-31
Feb 28, 2025
8-K
Results of operations (earnings release)
Feb 11, 2025
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Results of operations (earnings release)
Oct 24, 2024
8-K
Regulation FD disclosure
Sep 3, 2024
10-Q
Quarter ended 2024-06-30
Jul 31, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Jul 24, 2024
8-K
Regulation FD disclosure; Other events
Jul 15, 2024
8-K
Director or officer change
Jul 10, 2024
8-K
Director or officer change
Jun 17, 2024
8-K
Regulation FD disclosure; Other events
Jun 3, 2024
8-K
Shareholder vote results
May 8, 2024
10-Q
Quarter ended 2024-03-31
Apr 29, 2024
8-K
Results of operations (earnings release)
Apr 25, 2024
8-K
Director or officer change
Mar 26, 2024
10-K
Fiscal year ended 2023-12-31
Feb 12, 2024
8-K
Results of operations (earnings release)
Feb 6, 2024
8-K
Regulation FD disclosure; Other events
Dec 7, 2023
10-Q
Quarter ended 2023-09-30
Oct 27, 2023
8-K
Results of operations (earnings release)
Oct 25, 2023
10-Q
Quarter ended 2023-06-30
Jul 28, 2023